심장 보철 기기 시장 규모, 점유율, 성장 분석 : 제품 유형별, 재질 유형별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Global Cardiac Prosthetic Devices Market size was valued at USD 7.47 Billion in 2024 and is poised to grow from USD 8.05 Billion in 2025 to USD 14.69 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global market for cardiac prosthetic devices is primarily driven by the growing elderly population, which experiences structural and functional changes in the cardiovascular system, increasing susceptibility to conditions such as aortic stenosis and heart failure. This demographic shift leads to a heightened incidence of degenerative heart diseases, necessitating surgical or percutaneous interventions involving prosthetic valves or pacemakers. Consequently, there is a surging demand for advanced cardiac prosthetic devices, influenced by rising hospital admissions and medical procedures. Additionally, technological innovations play a crucial role, with developments such as minimally invasive options, biocompatible materials, and 3D-printed valves enhancing safety, effectiveness, and long-term outcomes. These advancements not only improve post-operative care through smart monitoring solutions but also expand treatment options, ensuring sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide serves as a significant catalyst for the expansion of the global cardiac prosthetic devices market. As conditions such as heart valve disease and coronary artery conditions become more common, there is a heightened demand for prosthetic solutions like heart valves and vascular grafts. This surge in need not only drives sales but also encourages advancements and innovation within the industry, creating a dynamic environment for growth and development in cardiac healthcare technologies. Consequently, the ongoing battle against these health challenges continues to propel the market forward, leading to enhanced treatment options for patients.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The stringent regulatory requirements, coupled with the need for comprehensive clinical trials and extensive testing, can impede the timely introduction of new devices. This protracted approval timeline not only stifles innovation but also limits patient access to the latest advancements in cardiac technology. As a result, the market may suffer from delays that prevent the adoption of potentially life-saving solutions, ultimately impacting patient care and overall progress in treating cardiac conditions.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly gravitating towards advancements in minimally invasive procedures, reflecting a significant trend in patient preference and clinical practice. These innovative devices, such as transcatheter heart valves and catheter-based repair systems, are gaining traction due to their ability to promote quicker recovery times and lower associated risks compared to traditional surgical approaches. The shift towards smaller incisions not only enhances patient comfort but also improves overall outcomes, driving demand for these technologies. As healthcare providers prioritize efficiency and patient satisfaction, the market is expected to see continued growth fueled by these minimally invasive solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Transcatheter Heart Valves (TAVR)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Others
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Biological Materials
  • Bovine Pericardium
  • Porcine Tissue
• Synthetic Materials
  • Titanium
  • Polyurethane
  • Carbon
• Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers and Clinics
• Ambulatory Surgical Centers
• Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, End-Use)
  • US
  • Canada
• Europe (Product Type, Material Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcor Laboratorios Ltda. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations